ISIF, WuXi and GMI launch $400 mln program to boost Ireland as genomics research hub
The Ireland Strategic Investment Fund, WuXi NextCODE and Genomics Medicine Ireland have launched a $400 million investment program aimed at making Ireland a hub for genomics research and development of new disease treatments and cures. The other investors in this initiative include ARCH Venture Partners, Polaris Partners, Temasek, Yunfeng Capital and Sequoia Capital.
27 November 2018•5 mins read
